AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LONDON, GREATER LONDON, UK, January 1, 2024 /EINPresswire.com/ -- Year End Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports
The Business Research Company’s “Thyroid Cancer Drugs Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the thyroid cancer drugs market size is predicted to reach $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 14.1%.
The growth in the thyroid cancer drugs market is due to increasing incidences of thyroid cancer, especially in women. North America region is expected to hold the largest thyroid cancer drugs market share. Major players in the thyroid cancer drugs market include Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Baxter International Inc., Abbott Laboratories, APP Pharmaceuticals LLC.
Thyroid Cancer Drugs Market Segments
• By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types
• By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types
• By End Users: Hospitals, Oncology Clinics, Research Organizations, Other End-Users
• By Geography: The global thyroid cancer drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=2601&type=smp
The thyroid cancer drugs refer to drugs that are used to treat thyroid cancer by blocking several different kinase proteins. These medications function primarily in two ways. First, they aid in preventing Tumors from growing new blood vessels, which they require to do so. They target a few of the proteins that cancer cells often produce to aid in their growth. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops.
The main types of thyroid cancer drugs are radioiodine ablation, thyroid stimulating hormone (THS) suppression, chemotherapy, targeted multikinase therapy, and others. Radioiodine ablation is a type of radiation therapy that uses radioactive iodine to remove or ablate any healthy thyroid tissue that remains following a thyroidectomy. The different types of drugs include ipilimumab, cabozantinib-s-malate, caprelsa (vandetanib), doxorubicin hydrochloride, and lenvatinibmesylate, nivolumab, vandetanib, others and are used in various sectors such as hospitals, oncology clinics, research organizations, others.
Read More On The Thyroid Cancer Drugs Global Market Report At:
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-reportv
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Thyroid Cancer Drugs Market Characteristics
3. Thyroid Cancer Drugs Market Trends And Strategies
4. Thyroid Cancer Drugs Market – Macro Economic Scenario
5. Thyroid Cancer Drugs Market Size And Growth
……
27. Thyroid Cancer Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis
30. Appendix
Browse Through More Similar Reports By The Business Research Company:
Drugs For Erectile Dysfunction Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-reportv
Drugs For Benign Prostatic hypertrophy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report
Diuretics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report
Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
